Hosted on MSN10d
Researchers identify a gene to guide novel therapeutics of nonalcoholic fatty liver diseasesAbout 25% of NAFLD patients progress to a more severe stage including liver inflammation (nonalcoholic steatohepatitis, NASH) ...
Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...
Non-alcoholic fatty liver disease has no early signs. Is your liver at risk? Expert reveals these simple tests could save ...
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
"A higher FT3/FT4 ratio was associated with an increased risk of developing NAFLD (OR 1.45) and greater severity of liver fibrosis (ORs 3.21–10.80), highlighting the potential role of thyroid hormones ...
Sleep deprivation leads to increased production of free fatty acids and triglycerides. World Sleep Day special ...
Intermittent fasting (IF) shows promise for improving fatty liver disease by reducing liver fat, inflammation, and enhancing ...
Ready to save your liver? Transcription factors are paving the way for metabolic dysfunction-associated fatty liver disease ...
A fatty liver is the most common. Dr Sudeep Khanna, senior consultant, gastroenterology, Indraprastha Apollo Hospitals, ...
6d
News-Medical.Net on MSNStudy reveals the role of transcription factors as therapeutic gateways in MAFLDMetabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results